← Evidence map

ReviewFrontiers in bioengineering and biotechnology2026

Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing.

Roger Hart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42761237